Crossmark

Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide-based regimen for prevention of graft-versus-host disease in haploidentical peripheral blood stem cell transplantation for pediatric patients with hematologic malignancies

Crossref DOI link: https://doi.org/10.1007/s00277-024-05883-w

Published Online: 2024-07-10

Published Print: 2024-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Du, Yanlu

Zhang, Ying

Xu, Xiaowei

Cai, Yu

Wei, Yu

Huang, Chongmei

Yang, Jun

Qiu, Huiying

Niu, Jiahua

Zhou, Kun

Xia, Xinxin

Shen, Chang

Tong, Yin

Dong, Baoxia

Wan, Liping

Song, Xianmin
Funding

Funding for this research was provided by:

Shanghai Shen Kang Hospital Development Center (SHDC2020CR1012B)

Clinical Research Innovation Plan of Shanghai General Hospital (CTCCR-2018BP03)
License Information

Text and Data Mining valid from 2024-07-10

Version of Record valid from 2024-07-10
More Information

Article History

Received: 23 April 2024

Accepted: 4 July 2024

First Online: 10 July 2024

Declarations

:

: The authors declare no competing interests.

: The authors declare no conflict of interest.

: This study was approved by the Ethics Committee of the coordinating institution of Shanghai General Hospital (Code:2022KY023).

Document is current

Any future updates will be listed below